Like other physiological responses, immune functions are the subject of behavioural conditioning. Conditioned immunosuppression can be induced by contingently pairing a novel taste with an injection of the immunosuppressant cyclosporine A (CsA) in an associative learning paradigm. This learned immunosuppression is centrally mediated by the insular cortex and the amygdala. However, the afferent mechanisms by which the brain detects CsA are not understood. In this study we analysed whether CsA is sensed via the chemosensitive vagus nerve or whether CsA directly acts on the brain. Our experiments revealed that a single peripheral administration of CsA increases neuronal activity in the insular cortex and the amygdala as evident from increased electric activity, c-Fos expression and amygdaloid noradrenaline release. However, this increased neuronal activity was not affected by prior vagal deafferentation but rather seems to partially be induced by direct action of CsA on cortico-amygdaloid structures and the chemosensitive brainstem regions area postrema and nucleus of the solitary tract. Together, these data indicate that CsA as an unconditioned stimulus may directly act on the brain by a still unknown transduction mechanism.
Introduction
The peripheral immune system can be modified by Pavlovian conditioning, being part of the learned placebo response (Ader, 2003 ; Enck et al. 2008 ; Schedlowski & Pacheco-Lopez, 2010 ; Vits et al. 2011) . By employing taste associative learning, the immunosuppressive properties of cyclosporine A (CsA) can be mimicked as a learned response ; calcineurin activity, cytokine production and proliferative capacity are inhibited in splenic T lymphocytes from behaviourally conditioned rats after re-exposure to the gustatory conditioned stimulus PachecoLopez et al. 2009 ). This learned immunosuppression is b-adrenoceptor-dependent (Exton et al. 2002) and centrally mediated by cortico-limbic substrates (Pacheco-Lopez et al. 2005) . Excitotoxic lesions of the insular cortex (IC) block acquisition as well as evocation of both the learned immune response and the learned taste avoidance, whereas amygdala (AM) lesions solely affect the visceral input necessary for the acquisition of the learned immunosuppression, but without affecting the taste avoidance development (Pacheco-Lopez et al. 2005) , indicating the potential dissociability of these two engrams.
The neural network underlying the acquisition of taste-visceral associations includes both sensory and hedonic pathways (Sewards, 2004) . Particularly, the IC integrates gustatory and visceral stimuli (BermudezRattoni & McGaugh, 1991 ; Cubero et al. 1999 ; Sewards & Sewards, 2001) , generating the human emotion of 'disgust ' (Harrison et al. 2010) . In addition to fear processing, the AM plays an important role during the formation of avoidant ingestive behaviour (BermudezRattoni, 2004 ; Reilly & Bornovalova, 2005) and noradrenergic input to the AM modulates taste-visceral learning and memory processes (Berman & Dudai, 2001 ; Miranda et al. 2003) . In particular, peripheral immune activation (e.g. by bacterial lipopolysaccharide or superantigens) induces a fast and robust amygdaloid response documented by increased c-Fos expression, increased electrical activity and enhanced noradrenaline release (Buller & Day, 2002 ; Doenlen et al. 2011 ; Engler et al. 2011 ; Gaykema et al. 2007) and induces strong learned taste avoidance (PachecoLopez et al. 2004 (PachecoLopez et al. , 2008 . However, taste reactivity seems to be not affected, indicating no changes in palatability or aversion development (Cross-Mellor et al. 2004) . The vagus nerve is anatomically well situated to sense immune-related information (Berthoud & Neuhuber, 2000 ; Goehler et al. 2000) and many behavioural responses and autonomic reflexes induced by immunomodulators are inhibited or completely blunted by vagotomy (Fleshner et al. 1998 ; Romanovsky et al. 1997) . Alternatively, humoral afferent routes have been identified, indicating that cytokines or prostaglandins reach the brain via the circumventricular organs (Quan & Banks, 2007) or cerebral vasculature (Serrats & Sawchenko, 2009 ; Serrats et al. 2010) . In contrast, only little is known about how immunosuppressants affect the brain and, at present, the afferent pathway underlying CsA as an unconditioned stimulus is completely unknown. Direct brain penetration of CsA has been neglected due to the limited transport across the blood brain barrier (Cefalu & Pardridge, 1985) and by its selective elimination via P-glycoprotein on the cerebral microvasculature endothelium (Sakata et al. 1994 ; Shiga et al. 1992) . Furthermore, a vago-sympathetic reflex was identified as the underlying mechanism of CsAinduced hypertension (Lyson et al. 1994 ; Moss et al. 1985) , indicating a direct peripheral action of CsA on the vagus nerve terminals (Zhang et al. 2000) . Therefore, to elucidate the sensory process underlying taste-CsA association, we investigated two different possibilities : (a) CsA is detected via the chemosensitive vagus nerve ; (b) CsA directly penetrates the brain. To accomplish this goal, we analysed electrical activity in the IC and the AM during the first hours after CsA administration. Concomitantly, c-Fos as well as changes in AM noradrenergic extracellular concentrations were assessed. Since cytokines have been shown to modulate neural plasticity involved in associative learning (Balschun et al. 2004 ; Rachal Pugh et al. 2001 ), brain cytokine mRNA expression was analysed at particular time points. Finally, the vagus role vs. a direct route of action were tested by selective vagal deafferentation (SDA) surgery and by CsA quantification in brain parenchyma, respectively.
Materials and method

Animals
Male Dark Agouti rats (DA/OlaHsd, 250-270 g) were single housed and maintained on a 12-h light/dark cycle (lights on 19:00 hours) with free access to food and water unless described otherwise. All procedures were in accordance with international standards, the Swiss Federal Act on Animal Protection and the German Animal Welfare Act.
Experimental design
To avoid any pharmacological and/or psychological carry-over effect, seven different cohorts of animals were used, analysing particular parameters in a between subjects design. Table 1 summarizes the different experiments, parameters analysed and cohort characteristics. In all experiments, CsA (Sandimmune ; Novartis, Switzerland) was administered i.p. at a dose of 20 mg/kg dissolved in sterile saline as vehicle.
Associative learning
Cohort 1
To induce associative learning, we followed a wellestablished and validated conditioning protocol, reported in detail elsewhere . Briefly, 5 d prior to the single association trial, animals were placed on a water deprivation regimen, allowing them to drink for 15 min at 08:00 hours and for another 15 min at 17:00 hours each day. During association, in the morning session animals received saccharin solution (0.2 % w/v) as a conditioned stimulus and afterwards an i.p. injection of 20 mg/kg CsA as an unconditioned stimulus. The inter-stimuli interval (i.e. time from end of saccharin exposure to CsA injection) was <30 min for all animals. In the afternoon session, water was given in combination with an i.p. injection of vehicle. Non-contingent pairing was achieved by presenting the same stimuli but saccharin solution was offered 24 h prior to CsA injection. After a break of 3 d, during which the water deprivation regimen was maintained, evocation trials started by giving the animals saccharin solution in the morning sessions and water in the afternoon sessions (Fig. 1 a) .
c-Fos immunohistochemistry
Cohort 2
Rats received i.p. injections of CsA or vehicle and were deeply anaesthetized 120 min after treatment. Animals were transcardially perfused, brains fixed (4 % paraformaldehyde in PBS) and coronally sectioned to perform c-Fos immunohistochemistry, where c-Fos immunoreactive cells were estimated by the optical fractionator method (Gundersen et al. 1988) following an unbiased stereology approach, as previously reported (Engler et al. 2011) . A semi-automatic microscope equipped with a motorized stage was coupled to a digital camera connected to a computer equipped with Mercator Pro software (Explora Nova, France).
Deep brain electroencephalography (EEG)
Cohort 3
Electrode implantation and recordings were performed as described previously ). Brain coordinates for IC (anterior +1.6 mm, lateral 4.8 mm, ventral 6.5 mm) and AM (posterior x2.5 mm, lateral 4.3 mm, ventral 8.0 mm) were selected based on earlier studies , corresponding to the anterior IC and the caudal AM, responsible for visceral processing (Bagaev & Aleksandrov, 2006 ; Sewards, 2004) . Lateralization was controlled by equally distributing left and right hemispheres across the groups. Baseline EEG activity was obtained 1 h before treatment during three 5-min recording blocks that were separated by 10-min intervals. After CsA or vehicle injection, neural recording was continued in the same mode as prior to injection and was terminated 200 min after the treatment. Data were analysed as power index (total power at a given time point/ baseline total power) to account for the changes over time. To compute the magnitude of change, an integrated power index was calculated as the area under the curve during the whole recording period (20-200 min).
In vivo microdialysis
Cohort 4
Guide cannula surgery and intracerebral microdialysis probe implantation were performed as previously described (Krugel et al. 2003) . Animals were equally distributed for left or right AM to account for potential lateralization. Five samples were taken to determine the baseline noradrenaline concentration. Three minutes before the end of the fifth sample, the animals were gently lifted and injected with either CsA (n=6) or vehicle (n=5). Dialysate samples were collected in 20-min intervals until 260 min after drug injection. At the end of the 260-min sample all animals received an i.p. injection of adrenaline (0.1 mg/kg body weight ; Mibe, Germany) as a positive control (Williams et al. 2000) and the sampling was continued for an additional 100 min. The correct placement of the microdialysis probe was verified histologically at the end of the experiment. Noradrenaline levels in brain dialysate samples were analysed by high-performance liquid chromatography as previously described (Krugel et al. 2003) .
Selective vagal deafferentation
Cohort 5 Surgery was performed as previously described (Arnold et al. 2006) . Briefly, SDA is achieved by selective lesion of the afferent vagal fibre at peribrainstem level, where afferent rootlets were sectioned on the left side. Afterwards, ipsilateral abdominal vagotomy was carried out to lesion the afferent and efferent fibres connected contralaterally to the side of the rootlet section (Fig. 3a) . The sham procedure consisted of similarly opening the skull and abdomen to expose the vagal rootlets and abdominal vagus, but no further manipulating them. A cholecystokinin test functionally confirmed SDA, since cholecystokinin satiation depends on intact abdominal vagal afferent fibres (Monnikes et al. 1997) . Before dark onset, cholecystokinin was i.p. injected at 4 mg/kg dose (Bachem, Switzerland) for the SDA and sham groups. Cumulative food intake was assessed at 30 min, 1 and 2 h post-injection. Post-mortem histological verification assessed the retrograde labelling of flurogold (2 mg/ml i.p., 3 d before killing). After perfusion, and sectioning, the dorsal subdiaphragmatic vagal nerve transaction was verified in each SDA rat (Fig. 3 a) .
To evaluate c-Fos expression, animals were divided into four different treatment groups : the shamoperated CsA (sham/CsA) and SDA CsA (SDA/CsA) groups were treated with CsA ; the sham-operated vehicle (sham/vehicle) and SDA vehicle (SDA/vehicle) groups were injected with vehicle. At 120 min after CsA or vehicle injections, animals were deeply anaesthetized with isoflurane and perfused transcardially to perform c-Fos immunohistochemistry (as mentioned above).
Brain cytokine mRNA expression
Cohort 6
Rats received either CsA or vehicle i.p. and were killed by decapitation 120, 240 and 360 min after treatment. Brains were carefully removed, immediately snap frozen in liquid nitrogen and stored at x80 xC. Sections of 300 mm thickness were cut coronally from frozen brains using a cryostat set to x5 xC and were placed on pre-chilled glass slides. The area of interest was dissected by a micropunch technique as described elsewhere (Palkovits & Brownstein, 1988) . Total RNA was isolated and gene expression analysis was performed by real-time quantitative PCR as previously described (Engler et al. 2011) using TaqMan Gene Expression Assays (Applied Biosystems, Switzerland) for interleukin (IL)-1b (Rn00580432_m1), IL-2 (Rn00587673_m1), IL-6 (Rn00561420_m1), interferon (IFN)-c (Rn00594078_m1) and tumour necrosis factor (TNF-a ; Rn99999017_m1). Eukaryotic 18S rRNA (#4319413E ; Applied Biosystems) was used as endogenous control. Relative gene expression was calculated according to the 2 xDDCt method (Livak & Schmittgen, 2001 ).
CsA quantification
Cohort 7
Rats received i.p. injections of either CsA or vehicle and were killed by decapitation 120 and 240 min after treatment. Trunk blood was collected into EDTAtreated tubes and stored frozen until analysis. Unperfused brains were processed as previously described . Briefly, on frozen coronal section (300 mm thick) specific brain regions were microdissected using the micropunch technique described above. Spleens were removed and snap frozen in liquid nitrogen. The concentration of CsA was determined as previously reported .
Data analysis
Data were analysed using SPSS (version 17.0 ; IBM, USA) for parametric assumptions and concomitant statistical tests (parametric or non-parametric) were employed with a common level of significance set at p<0.05. Specific statistical tests employed and sample sizes are mentioned in the text and figure legends.
Results
CsA induces taste associative learning
A single pairing of saccharin with an i.p. injection of CsA induced associative learning (Fig. 1 a) . Besides the expected neophobia on the first encounter with saccharin, animals receiving CsA paired with saccharin (n=5) displayed significant avoidance behaviour towards the conditioned stimulus (t 4 =x5.8, p<0.05 ; paired t test first evocation vs. association trial). The conditioned taste avoidance was robust since three repeated evocation trials did not reduce the magnitude of this behaviour.
Enhanced neural electrical activity after CsA injection
Time-dependent changes in neuronal activity in ipsilateral AM and IC were analysed by deep brain EEG (Fig. 1 c ; CsA n=10, vehicle n=10-11). Baseline total EEG power in IC and AM, respectively, did not significantly differ between left and right brain hemispheres (IC left 5720¡363 vs. right 5134¡362 mV, t 19 =1.1, p=0.27 ; AM left 6355¡425 vs. right 5539¡525 mV, t 19 =1.14, p=0.26, unpaired t test). Thus, total EEG power of both brain sides was pooled for each structure. Administration of CsA significantly increased neural activity over time in both AM and IC (Fig. 1 b) 
Enhanced amygdaloidal noradrenaline release after CsA injection
Taste-visceral associative learning is mediated via b-adrenoceptors in the AM (Miranda et al. 2003) and noradrenergic input to the AM is related to vagal nerve stimulation (Williams et al. 2000) . Therefore, we monitored extracellular noradrenaline levels in the AM after i.p. administration of CsA and vehicle, respectively. Basal concentration of noradrenaline in dialysates was 1.5¡0.3 nM (n=11) and CsA administration (n=6) induced a pronounced increase in noradrenaline concentration in AM dialysates compared to the vehicle-treated group (n=5, Fig. 1 c) . Repeated measure ANOVA revealed significant main effects of time (F 1,9 =8,161, p<0.05) and treatment (F 1,262 =6,787, p<0.05) as well as a significant timertreatment interaction (F 1,9 =1,694, p<0.05). Post-hoc analysis showed that CsA enhanced noradrenaline levels significantly (p<0.05) from 40 to 140 min and from 220 to 260 min by about 145 %. Administration of adrenaline (0.1 mg/kg i.p.) was used as internal control since previous studies have shown that this leads to an immediate and sustained elevation in amygdaloidal noradrenaline concentrations (Williams et al. 2000) .
Noradrenaline concentration in AM dialysates significantly increased in both groups following adrenaline administration but this effect was more sustained in the vehicle group.
CsA induces c-Fos expression in the brain
Immunohistochemistry for c-Fos was used to localize and quantify activated neurons within the AM and IC (Fig. 1 d) . Unbiased stereological analysis of c-Fos expression showed that a single i.p. injection of 20 mg/kg CsA resulted in a significant increase in the number of c-Fos immunoreactive cells in the AM (n=4 ; t 6 =8.9, p<0.05) as well as in the IC (n=5; t 7 =2.5, p<0.05) compared to vehicle-injected animals (n=4).
CsA induces expression of inflammatory cytokines in the brain
Cytokines have been shown to modulate neural functions such as learning and memory. Thus, we measured cytokine gene expression in amygdaloid micropunch samples at 120, 240 and 360 min following a single administration of CsA or vehicle (Fig. 2) . Injection of CsA significantly increased mRNA expression of IL-1b at 240 min (U=30.0, z=x2.08, p<0.05) and 360 min (U=28.0, z=x2.49, p<0.05), IL-6 at 360 min (U=30.0, z=x2.38, p<0.05) and TNF-a at 240 min (U=30.0, z=x2.08, p<0.05) and 360 min (U=26.5, z=2.58, p<0.05) (Fig. 2) . In addition, CsA treatment induced >15-fold, significant increase in IFN-c mRNA expression at 360 min after injection (U=35.0, z=x2.10, p<0.05). In contrast, IL-2 mRNA expression remained unaffected.
The vagus nerve is not essential for CsA central effects
The vagus nerve has been suggested as one major route via which peripheral immune signals might be transmitted to the brain, as well as underlying CsA-induced hypertension mediated by the brainstem. Thus, we performed SDA and sham surgery, respectively, to analyse whether CsA-induced neurobehavioural changes associated with taste-CsA learning depend on intact vagal afferents. Functional and histological analyses confirmed successful vagal deafferentation (Fig. 3a, b) . Retrograde fluorogold tracer was present in neurons labelled on the left dorsal motor nucleus of the vagus, consistent with an intact ventral vagal efferent trunk and the absence of labelling in the right dorsal motor vagal nuclei, which are normally supplied by the transected dorsal subdiapragmatic vagal trunk (Fig. 3 a) . Furthermore, injection of cholecystokinin induced an acute but significant reduction of cumulative food intake in sham but not SDA animals (t 12 =5.6, p<0.05), providing functional evidence for successful selective vagal deafferentation in all the SDA animals ( Fig. 3 b) .
Because vagal afferents terminate in the nucleus of the solitary tract (NTS), we further analysed the CsA-induced pattern of c-Fos immunoreactivity in the brainstem of SDA and sham-operated animals (Fig. 3 c,  Supplementary Fig. 1 ). Irrespective of vagal integrity, CsA injection led to a significant increase of c-Fos expression in the NTS and area postrema (AP) of SDA (t 13 =4.5, p<0.05) and sham-operated rats (t 10 =5.2, p<0.05), suggesting that the afferent vagus is not involved in CsA-induced brain activation. This view is further supported by the observation that CsA injection significantly enhanced c-Fos expression on the AM and IC not only in intact (t 10 =7.2, p<0.05, t 10 =2.5, p=0.06) but also in SDA (t 13 =4.6, p<0.05, t 13 =5.4, p<0.05) animals, respectively.
SDA animals developed a strong conditioned taste avoidance similar to sham animals (Fig. 3 d) . Both groups showed a significant reduction of saccharin intake after the association trial and the first evocation (SDA, t 9 =x5.4, p<0.05 ; sham t 9 =x4.4, p<0.05).
CsA is detectable in the brain after a single peripheral administration
CsA levels were determined in peripheral blood, spleen and different brain areas (IC, AM, cerebellum). High levels of CsA were found in the peripheral blood and the spleen at 120 as well as 240 min after injection (Fig. 4 a) . More importantly, however, substantial amounts of CsA were also detectable in the IC (t 5 =3.3, p<0.05), AM (t 4 =3.1, p<0.05) and cerebellum (t 5 =5.0, p<0.05) at both time points (Fig. 4 b) .
Discussion
Behavioural conditioning of immune functions demonstrates bidirectional communication between the brain and the immune system. However, how a peripheral administered immunosuppressant becomes an unconditioned stimulus is not yet understood. Based on a well-established associative learning paradigm in rodents, using saccharin taste as a conditioned stimulus and the immunosuppressant CsA as an unconditioned stimulus , we demonstrate here that a single i.p. administration of CsA is sufficient to elicit a robust conditioned taste avoidance. This behavioural effect is associated with enhanced cortico-limbic electrical activity and increased noradrenergic input to the AM. Post-mortem analyses of c-Fos and cytokine mRNA expression confirmed a pronounced activation in the AM and IC. Importantly, however, the CsA-induced c-Fos expression and conditioned taste avoidance are not affected by prior vagal deafferentation. In contrast, the fact that CsA is detected in the brain parenchyma and that c-Fos expression was significantly enhanced in the chemosensory brainstem complex NTS/AP points towards a potential direct action on neural activity.
Taste-induced conditioned immuno-pharmacological response depends on three consecutive steps : (a) the unconditioned stimulus must be either directly sensed by the brain or indirectly recognized via changes in the immune response ; (b) the unconditioned stimulus must be associated with the tastetrace memory ; and finally (c) at evocation time, re-exposure to the conditioned stimulus must retrieve such memory and subsequently modify the immune system (Ader & Cohen, 2001 ; Grossman et al. 1992 ; Riether et al. 2008) . Employing CsA as an unconditioned stimulus in an associative learning paradigm, we have documented the necessity of the IC and AM for taste-CsA association (Pacheco-Lopez et al. 2005) . Memory retrieval of the learned immunosuppression depends on hypothalamic integrity and intact splenic innervation, mediated by splenocytes badrenoceptors and calcineurin intracellular activation to prolong heart allograft survival and to suppress allergic reactions (Exton et al. 1999 (Exton et al. , 2000 Riether et al. 2011) . Although the neural mechanisms of gustation and the taste-trace memory are reasonably understood (Bermudez-Rattoni, 2004 ; Simon et al. 2006) , much less is known about the afferent mechanisms during acquisition, which allow the brain to receive information regarding the drug itself used as an unconditioned stimulus or by the drug-induced immune changes. Thus, a critical unsolved question is how an immunosuppressant such as CsA can signal the brain. Based on the ample evidence indicating that the brain developed the capacity to sense increases of peripheral cytokine concentration via the vagus nerve (Dantzer, 2001 ; Goehler et al. 2000) , a plausible possibility was that the brain also sensed unbalanced cytokine levels after CsA. Furthermore, it has been reported that CsA-induced hypertension (Lyson et al. 1994 ; Moss et al. 1985) is dependent on direct CsA stimulation of vagal afferents (via a Synapsin I and II mechanism) to induce a vago-sympathetic autonomic reflex (Zhang et al. 2000) . Although, deep brain EEG and microdialysis data, together with post-mortem c-Fos immunohistochemistry, clearly confirm activation in the IC and AM as early as 60 min after i.p. administration of CsA, SDA animals lacking vagal afferents were also able to associate a novel taste with the peripheral administration of CsA. In addition, SDA animals showed c-Fos expression in the AM and IC after CsA injection at similar levels as the sham control group, indicating that the vagus is not an essential afferent route for transmitting CsA information to the brain. We hypothesize that CsA might induce taste-associative learning via the activation of the blood chemo-sensitive brainstem complex AP/NTS, since we found strong c-Fos expression in both structures independent of vagal deafferentation. In this regard, AP lesions have been shown to attenuate lithium chloride-induced conditioned taste avoidance/aversion (Curtis et al. 1994 ; Rabin et al. 1983 ) and this lesion further blocks lithium chloride-induced c-Fos expression in the NTS (Yamamoto et al. 1992) . However, only further experimentation would elucidate the necessity of the AP as the main CsA transduction point. Despites its lipophilicity, initial pharmacological characterization suggested a restricted CsA brain penetration (Begley et al. 1990 ; Cefalu & Pardridge, 1985) . CsA binds to plasma proteins and is sequestrated by erythrocytes (Mraz et al. 1983) , limiting its transport across the blood brain barrier (Cefalu & Pardridge, 1985) . In addition, CsA is selectively eliminated by P-glycoprotein, a secretory transporter abundantly present in the brain capillary endothelium (Sakata et al. 1994 ; Shiga et al. 1992 ) and brain CsA concentration measurements are claimed to be only allocated to the capillary blood (Tanaka et al. 2000) . In contrast, evidence has accumulated documenting CsA brain permeability. For instance, 15-30 min after i.v. application (10 mg/kg), CsA was detected in brain homogenates at 10-fold higher blood concentrations (Vachon et al. 2002) . Similarly, after oral administration (82 mg/kg) CsA concentration peaked in the brain 2-7 h post ingestion (Nooter et al. 1984) . As in these reports, we analysed CsA concentrations in unperfused brains ; thus, there are three potential compartments for CsA accumulation in the brain, namely : (a) brain parenchyma ; (b) endothelium ; (c) blood trapped in the cerebral microvasculature (Vachon et al. 2002) . It has been recently calculated that the absolute cerebral blood volume in the rat is 21 ml/g (Adam et al. 2003) , comparable to the human parameter : 35 ml/g (Koshimoto et al. 1999) . Our average brain tissue sample was 4 mg=0.084 ml trapped blood. Considering the mean CsA blood concentration at the two selected time points (120 min=3750 ng/ml and 240 min=2500 ng/ml ; Fig. 4 a) , the CsA in brain samples due to blood is therefore, at most, 72.4 ng/g at 120 min and 52.5 ng/g at 240 min. This calculation clearly indicates that at 120 min the CsA detected in the brain samples could be mainly allocated to the cerebral blood, as has been suggested (Tanaka et al. 2000) . However, at the late time point, all the brain structures analysed show at least two-fold higher blood CsA concentration, confirming that CsA can indeed directly act on neurons even after a single i.p. administration of a moderate dose (20 mg/kg). Such time accumulation drift confirms that, after saturation of the P-glycoprotein pump, brain CsA levels increase (Tanaka et al. 2000) which is in agreement with the brain CsA concentration found after 6 d with 10 mg/kg.d dose .
Although, neurobehavioural evidence further supports fast CsA action on brain neurochemistry Sato et al. 2007 ; von Horsten et al. 1998) , the present data do not provide conclusive evidence that a direct CsA action on neurons is the transduction mechanism responsible for the formation of taste-CsA association, nor to the early corticolimbic activation. We hypothesize that the noradrenergic input to the AM might act as a putative unconditioned stimulus associated with the saccharin taste-trace memory. However, in vivo receptor blockade experiments will be essential to elucidate the neurochemical nature of the unconditioned stimulus.
Our data do not only demonstrate immediate neural effects induced by CsA but also show a paradoxical and late increase in mRNA expression of pro-inflammatory cytokines in the AM after CsA. Considering the neural plasticity requested for associative learning (Balschun et al. 2004 ; Rachal Pugh et al. 2001) , we initially assessed cytokine expression in the brain at different time points. However, CsA brain permeability at 240 min post-administration redimension these data in relation to whether and to what extent the pro-inflammatory profile detected at 240-360 min post-administration promotes the protection vs. toxicity associated with direct CsA action on neurons (Mazzeo et al. 2009 ; Okonkwo & Povlishock, 1999 ; Serkova et al. 2004 ). In the periphery, CsA binds to cyclophilin A (Takahashi et al. 1989) , to form a cytosolic drug-receptor complex inhibiting the protein phosphatase calcineurin (Liu et al. 1991) , finally inhibiting transcription of IL-2 and other cytokines and thus blocking the co-stimulation of activated T lymphocytes (Clipstone & Crabtree, 1992) . Although the brain is rich in calcineurin (Clipstone & Crabtree, 1992) and cyclophilin A is widely expressed by neurons (Goldner & Patrick, 1996) , recent data indicate that CsA effects in neurons are mainly mediated by the mitochondria bioenergetics (Klawitter et al. 2010 ; Serkova et al. 2004) . During neuronal injury, CsA inhibits the opening of the mitochondrial permeability transition pore by unbinding mitochondrial matrix cyclophillin from the pore (Broekemeier & Pfeiffer, 1995 ; Broekemeier et al. 1989 ) and thus protects mitochondria in the face of increased intracellular calcium, with its concomitant neurotoxic and apoptotic consequences (Mazzeo et al. 2009 ; Okonkwo & Povlishock, 1999) . CsA-neurotoxicity can also be explained by alterations of energy metabolism caused by a chronic inhibition of mitochondrial activity Serkova et al. 2002 Serkova et al. , 2004 . To what extent the pro-inflammatory profile observed in the brain after peripheral CsA administration reflects neurotoxic processes must be further investigated.
In summary, our data document the fast action of CsA on neural activity, measured by in vivo electrical recordings and microdialysis in the IC and AM as well as by post-mortem c-Fos mapping. In the context of taste-immune associative learning, the vagus nerve is not essential as the afferent route transmitting the CsA information to the brain. Instead, the chemosensory brainstem complex NTS/AP seems to be a good candidate to test for the transduction site of CsA. Furthermore, increased CsA levels detected in the IC and AM indicate a direct effect of CsA on neural activity with potential neurotoxic effects, but unlikely behind taste-CsA associative learning.
Note
Supplementary material accompanies this paper on the Journal's website (http://journals.cambridge.org/ pnp).
